Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Experimental & Molecular Medicine ; : 663-672, 2007.
Artigo em Inglês | WPRIM | ID: wpr-170420

RESUMO

An extracellular matrix protein plays an important role in skin wound healing. In the present study, we engineered a recombinant protein encompassing the 9th and 10th type III domains of fibronectin, and 4th FAS1 domain of beta ig-h3. This recombinant protein, in total, harbors four known-cell adhesion motifs for integrins: Pro-His-Ser-Arg-Asn (PHSRN) and Arg-Gly-Asp (RGD) in 9th and 10th type III domains of fibronectin, respectively, and Glu-Pro-Asp-Ile-Met (EPDIM) and Try-His (YH) in 4th FAS1 domain of big-h3, were designated to tetra-cell adhesion motifs (T-CAM). In vitro studies showed T-CAM supporting adhesion, migration and proliferation of different cell types including keratinocytes and fibroblasts. In an animal model of full-thickness skin wound, T-CAM exhibited excellent wound healing effects, superior to both 4th FAS1 domain of beta ig-h3 or 9th and 10th type III domains of fibronectin. Based on these results, T-CAM can be applied where enhancement of cell adhesion, migration and proliferation are desired, and it could be developed into novel wound healing drug.


Assuntos
Animais , Humanos , Camundongos , Coelhos , Motivos de Aminoácidos , Adesão Celular/efeitos dos fármacos , Linhagem Celular , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Proteínas da Matriz Extracelular/química , Fibroblastos/citologia , Fibronectinas/química , Queratinócitos/citologia , Células NIH 3T3 , Proteínas Recombinantes de Fusão/química , Fator de Crescimento Transformador beta/química , Cicatrização/efeitos dos fármacos
2.
Korean Journal of Nephrology ; : 301-310, 2007.
Artigo em Coreano | WPRIM | ID: wpr-162651

RESUMO

PURPOSE: Acute renal failure remains a potentially devastating clinical problem. This study aimed to examine whether the expression of TGF-beta-induced gene product, betaig-h3, is altered in ischemia- reperfusion (I/R) injury and urinary excretion of betaig-h3 is changed in I/R injury. METHODS: I/R injury was performed by clamping both renal arteries. Daily urine output, serum creatinine and urinary TGF-beta and betaig-h3 were measured after I/R injury. Also, the renal expression of betaig-h3 by western blotting and immunohistochemistry were investigated. In the second step, urinary betaig-h3 was measured at 4, 10, 16, and 24 hours after I/R injury to investigate whether it could be used as an early and sensitive marker for detecting I/R injury. RESULTS: Urinary betaig-h3 was significantly elevated at 24 hours and maintained higher than the controls until 2 days after I/R injury. In contrast, western blotting did not reveal any changes of betaig-h3 expression. Immunohistochemistry showed that labeling of betaig-h3 was seen at the basement membranes of proximal tubule cells mainly located at the medullary ray (S3 segment) in both groups. Following I/R injury, the labeling was also seen in the basement membrane of injured or regenerated proximal tubular epithelial cells. Within 24 hours, urinary betaig-h3 was significantly increased at 4 hours after I/R injury. Importantly, the urinary appearance of betaig-h3 preceded that of N-acetyl-beta-D-glucosaminidase. CONCLUSION: These results suggest that endogenous renal betaig-h3 may serve to promote tissue regeneration in I/R injury and urinary betaig-h3 could be used as an early and sensitive marker demonstrating I/R injury.


Assuntos
Acetilglucosaminidase , Injúria Renal Aguda , Membrana Basal , Western Blotting , Constrição , Creatinina , Células Epiteliais , Imuno-Histoquímica , Regeneração , Artéria Renal , Reperfusão , Traumatismo por Reperfusão , Fator de Crescimento Transformador beta
3.
Experimental & Molecular Medicine ; : 153-161, 2006.
Artigo em Inglês | WPRIM | ID: wpr-15696

RESUMO

Adhesion and migration of vascular smooth muscle cells (VSMCs) play an important role in the pathogenesis of atherosclerosis. These processes involve the interaction of VSMCs with extracellular matrix proteins. Here, we investigated integrin isoforms and signaling pathways mediating the adhesion and migration of VSMCs on betaig-h3, a transforming growth factor (TGF)-beta-inducible extracellular matrix protein that is elevated in atherosclerotic plaques. Adhesion assays showed that the alphavbeta5 integrin is a functional receptor for the adhesion of aortic VSMCs to betaig-h3. An YH18 motif containing amino acids between 563 and 580 of betaig-h3 was an essential motif for the adhesion and growth of VSMCs. Interaction between the YH18 motif and the alphavbeta5 integrin was responsible for the migration of VSMCs on betaig-h3. Inhibitors of phosphatidylinositide 3-kinase, extracellular signal-regulated kinase (ERK), and Src kinase reduced the adhesion and migration of VSMCs on betaig-h3. betaig-h3 triggered phosphorylation and activation of AKT, ERK, focal adhesion kinase, and paxillin mediating the adhesion and migration of VSMCs. Taken together, these results suggest that betaig-h3 and alphavbeta5 integrin play a role in the adhesion and migration of VSMCs during the pathogenesis of atherosclerosis.


Assuntos
Humanos , Animais , Quinases da Família src/antagonistas & inibidores , Fator de Crescimento Transformador beta/genética , Transdução de Sinais/fisiologia , Receptores de Vitronectina/genética , Proteínas Tirosina Quinases/antagonistas & inibidores , Paxilina/metabolismo , Miócitos de Músculo Liso/efeitos dos fármacos , Músculo Liso Vascular/citologia , Morfolinas/farmacologia , Dados de Sequência Molecular , Integrinas/genética , Flavonoides/farmacologia , MAP Quinases Reguladas por Sinal Extracelular/antagonistas & inibidores , Proteínas da Matriz Extracelular/genética , Inibidores Enzimáticos/farmacologia , Cromonas/farmacologia , Células Cultivadas , Movimento Celular/fisiologia , Adesão Celular/fisiologia , Sequência de Aminoácidos , Motivos de Aminoácidos/genética , Fosfatidilinositol 3-Quinase/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA